TGFB1 and neoplasm: Analysis of metastatic tumor tissues compared to the primary tumor showed persistent changes in the expression of cellular surface receptors, chronic inflammation, and the presence of proinflammatory cytokines (e.g., IL-17) and changes in downstream signaling pathways (TGF-β and MAPK signaling).